4//SEC Filing
HORIZON PHARMA, INC. 4
Accession 0001209191-11-042504
CIK 0001492426operating
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:17 PM ET
Size
31.3 KB
Accession
0001209191-11-042504
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2011-08-02+179,317→ 1,610,784 total - Conversion
Common Stock
2011-08-02$9.00/sh+362,366$3,261,294→ 1,973,150 total - Conversion
Series A Convertible Preferred Stock
2011-08-02−1,431,467→ 0 total→ Common Stock (1,431,467 underlying) - Conversion
Warrant to Purchase Common Stock
2011-08-02+14,315→ 14,315 totalExercise: $12.35Exp: 2016-07-02→ Common Stock (14,315 underlying) - Conversion
Common Stock
2011-08-02+1,431,467→ 1,431,467 total - Purchase
Common Stock
2011-08-02$9.00/sh+330,104$2,970,936→ 2,303,254 total - Conversion
Series B Convertible Preferred Stock
2011-08-02−179,317→ 0 total→ Common Stock (179,317 underlying) - Conversion
Convertible Promissory Notes
2011-08-02→ 0 totalExercise: $9.00→ Common Stock (362,366 underlying) - Conversion
Warrant to Purchase Series A Preferred Stock
2011-08-02−67,970→ 0 totalExercise: $5.20Exp: 2015-10-31→ Series A Preferred Stock (67,970 underlying) - Conversion
Warrant to Purchase Series A Preferred Stock
2011-08-02−33,985→ 0 totalExercise: $5.20Exp: 2016-07-02→ Series A Preferred Stock (33,985 underlying) - Conversion
Warrant to Purchase Series A Preferred Stock
2011-08-02−42,484→ 0 totalExercise: $5.20Exp: 2016-09-25→ Series A Preferred Stock (42,484 underlying) - Conversion
Warrant to Purchase Common Stock
2011-08-02+28,630→ 28,630 totalExercise: $12.35Exp: 2015-10-31→ Common Stock (28,630 underlying) - Conversion
Warrant to Purchase Common Stock
2011-08-02+17,895→ 17,895 totalExercise: $12.35Exp: 2016-09-25→ Common Stock (17,895 underlying)
Footnotes (6)
- [F1]Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
- [F2]Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
- [F3]These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the issuer's initial public offering of common stock.
- [F4]Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.
- [F5]Automatic conversion, in connection with the Issuer's initial public offering, of warrants to purchase Series A Preferred Stock into warrants to purchase Common Stock. The warrants converted at a rate of 2.374 shares of Series A Preferred Stock to 1 share of Common Stock.
- [F6]The warrants are immediately exercisable and shall terminate on the earlier of the expiration date referenced herein or the occurence of other specified corporate transactions.
Documents
Issuer
HORIZON PHARMA, INC.
CIK 0001492426
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001492426
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 5:17 PM ET
- Size
- 31.3 KB